Yang Hsin-Sheng, Matthews Connie P, Clair Timothy, Wang Qing, Baker Alyson R, Li Chou-Chi H, Tan Tse-Hua, Colburn Nancy H
Laboratory of Cancer Prevention, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702, USA.
Mol Cell Biol. 2006 Feb;26(4):1297-306. doi: 10.1128/MCB.26.4.1297-1306.2006.
Programmed cell death 4 (Pdcd4) suppresses neoplastic transformation by inhibiting the activation of c-Jun and consequently AP-1-dependent transcription. We report that Pdcd4 blocks c-Jun activation by inhibiting the expression of mitogen-activated protein kinase kinase kinase kinase 1 (MAP4K1)/hematopoietic progenitor kinase 1, a kinase upstream of Jun N-terminal kinase (JNK). cDNA microarray analysis of Pdcd4-overexpressing RKO human colon carcinoma cells revealed MAP4K1 as the sole target of Pdcd4 on the JNK activation pathway. Cotransfection of a MAP4K1 promoter-reporter with Pdcd4 demonstrated inhibition of transcription from the MAP4K1 promoter. Ectopic expression of Pdcd4 in metastatic RKO cells suppressed invasion. MAP4K1 activity is functionally significant in invasion, as overexpression of a dominant negative MAP4K1 (dnMAP4K1) mutant in RKO cells inhibited not only c-Jun activation but also invasion. Overexpression of a MAP4K1 cDNA in Pdcd4-transfected cells rescued the kinase activity of JNK. Thus, Pdcd4 suppresses tumor progression in human colon carcinoma cells by the novel mechanism of down-regulating MAP4K1 transcription, with consequent inhibition of c-Jun activation and AP-1-dependent transcription.
程序性细胞死亡4(Pdcd4)通过抑制c-Jun的激活以及随后的AP-1依赖性转录来抑制肿瘤转化。我们报道,Pdcd4通过抑制丝裂原活化蛋白激酶激酶激酶激酶1(MAP4K1)/造血祖细胞激酶1(一种位于Jun N端激酶(JNK)上游的激酶)的表达来阻断c-Jun的激活。对过表达Pdcd4的RKO人结肠癌细胞进行的cDNA微阵列分析显示,MAP4K1是Pdcd4在JNK激活途径上的唯一靶点。将MAP4K1启动子报告基因与Pdcd4共转染证明了对MAP4K1启动子转录的抑制作用。在转移性RKO细胞中异位表达Pdcd4可抑制侵袭。MAP4K1活性在侵袭中具有功能重要性,因为在RKO细胞中过表达显性负性MAP4K1(dnMAP4K1)突变体不仅抑制了c-Jun的激活,还抑制了侵袭。在转染了Pdcd4的细胞中过表达MAP4K1 cDNA可挽救JNK的激酶活性。因此,Pdcd4通过下调MAP4K1转录的新机制抑制人结肠癌细胞的肿瘤进展,从而抑制c-Jun激活和AP-1依赖性转录。